Charité - Universitätsmedizin Berlin
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1710-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.charite.de
Cold Contact Urticaria Treatment With Rilonacept
- First Posted Date
- 2014-06-24
- Last Posted Date
- 2018-07-17
- Lead Sponsor
- Charite University, Berlin, Germany
- Target Recruit Count
- 20
- Registration Number
- NCT02171416
- Locations
- 🇩🇪
University Berlin Charité ; Dermatology, Berlin, Germany
🇩🇪Universitätsmedizin, Mainz, Germany
Urticaria Facticia Treatment With Omalizumab (UFO)
- First Posted Date
- 2014-06-20
- Last Posted Date
- 2020-11-03
- Lead Sponsor
- Charite University, Berlin, Germany
- Target Recruit Count
- 61
- Registration Number
- NCT02169115
- Locations
- 🇩🇪
University Dermatology Freiburg, Freiburg, Germany
🇩🇪Dermatology University Mainz, Mainz, Germany
Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis
Phase 3
Completed
- Conditions
- Secondary Malignant Neoplasm of PeritoneumMalignant Neoplasm of StomachSecondary Malignant Neoplasm of Other and Unspecified Sites
- Interventions
- Procedure: HIPEC
- First Posted Date
- 2014-06-09
- Last Posted Date
- 2021-07-29
- Lead Sponsor
- Charite University, Berlin, Germany
- Target Recruit Count
- 105
- Registration Number
- NCT02158988
- Locations
- 🇩🇪
Klinik für Allgemein-, Visceral-, Gefäß- und ThoraxchirurgieCharité Campus Mitte, Berlin, Germany
Stroke Volume Analysis During Aortic Valve Replacement Trial
- Conditions
- Cardiac OutputCardiac SurgeryHemodynamic Monitoring
- First Posted Date
- 2014-06-05
- Last Posted Date
- 2014-08-08
- Lead Sponsor
- Charite University, Berlin, Germany
- Target Recruit Count
- 68
- Registration Number
- NCT02156856
- Locations
- 🇩🇪
Charité Universitätsmedizin Berin, Berlin, Germany
HEart and BRain Interfaces in Acute Ischemic Stroke
Completed
- Conditions
- StrokeAtrial Fibrillation
- First Posted Date
- 2014-05-20
- Last Posted Date
- 2018-07-18
- Lead Sponsor
- Charite University, Berlin, Germany
- Target Recruit Count
- 368
- Registration Number
- NCT02142413
- Locations
- 🇩🇪
Charité, University Medicine Berlin, Berlin, Germany
Medication Adherence and "True" Resistance in Patients With Resistant Hypertension
- Conditions
- Hypertension, Resistant to Conventional TherapyHypertensive Disease
- First Posted Date
- 2014-05-01
- Last Posted Date
- 2015-02-23
- Lead Sponsor
- Charite University, Berlin, Germany
- Target Recruit Count
- 50
- Registration Number
- NCT02128386
- Locations
- 🇩🇪
Medical Outpatient Department of the Charité - Universitätsmedizin Berlin, Berlin, Germany
Modulation of Visual-Spatial Learning in Patients With Mild Cognitive Impairment (MCI) by tDCS
Not Applicable
Completed
- Conditions
- Mild Cognitive Impairment (MCI)
- Interventions
- Device: tDCSBehavioral: training
- First Posted Date
- 2014-04-10
- Last Posted Date
- 2021-05-21
- Lead Sponsor
- Charite University, Berlin, Germany
- Target Recruit Count
- 21
- Registration Number
- NCT02110043
- Locations
- 🇩🇪
Charite Universitätsmedizin Berlin, Berlin, Germany
Modulation of Visual-Spatial Learning in Healthy Older Adults by tDCS
Not Applicable
Completed
- Conditions
- Healthy Older Adults
- Interventions
- Device: tDCSBehavioral: training
- First Posted Date
- 2014-04-10
- Last Posted Date
- 2018-01-30
- Lead Sponsor
- Charite University, Berlin, Germany
- Target Recruit Count
- 32
- Registration Number
- NCT02110056
- Locations
- 🇩🇪
Charite Universitätsmedizin Berlin, Berlin, Germany
Modulation of Visual-Spatial Learning in Healthy Young Adults by tDCS
Not Applicable
Completed
- Conditions
- Healthy Young Adults
- Interventions
- Device: tDCSBehavioral: training
- First Posted Date
- 2014-04-10
- Last Posted Date
- 2017-07-27
- Lead Sponsor
- Charite University, Berlin, Germany
- Target Recruit Count
- 24
- Registration Number
- NCT02110407
- Locations
- 🇩🇪
Charite Universitätsmedizin Berlin, Berlin, Germany
Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)
Phase 2
Terminated
- Conditions
- Myasthenia GravisSystemic Lupus ErythematosusRheumatoid Arthritis
- Interventions
- First Posted Date
- 2014-04-03
- Last Posted Date
- 2019-12-03
- Lead Sponsor
- Charite University, Berlin, Germany
- Target Recruit Count
- 11
- Registration Number
- NCT02102594
- Locations
- 🇩🇪
Charite - Universitätsmedizin Berlin, NeuroCure Clinical Research Center, Berlin, Germany
🇩🇪Charité - Universitätsmedizin Berlin, Internal Medicine / Rheumathology, Berlin, Germany
© Copyright 2025. All Rights Reserved by MedPath